- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hematological Malignancy in United Kingdom
Total 10421 results
-
University of Illinois at ChicagoCompleted
-
Merck Sharp & Dohme LLCActive, not recruitingHematological MalignanciesUnited States, Canada, Brazil, Chile, Denmark, France, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
M.D. Anderson Cancer CenterImmunoGen, Inc.Completed
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLCActive, not recruiting
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustCompletedA Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread (NICAM)Mucosal Lentiginous Melanoma | Acral Lentiginous Malignant MelanomaUnited Kingdom
-
Oregon Health and Science UniversityRecruiting
-
Anthony Sung, MDMassachusetts General HospitalCompleted
-
SanofiCompletedNeoplasm MalignantNetherlands, Belgium, Spain, Italy, United Kingdom
-
Sagimet Biosciences Inc.CompletedSolid Malignant TumorUnited Kingdom, United States
-
Massachusetts General HospitalConquer Cancer FoundationRecruitingLymphoma | Leukemia | Multiple Myeloma | Hematologic Malignancy | Blood CancerUnited States
-
SCRI Development Innovations, LLCBayerCompletedRefractory MalignancyUnited States
-
Henry Ford Health SystemRecruitingMyeloid MalignancyUnited States
-
St. Jude Children's Research HospitalChildren's Hospital of Philadelphia; National Institute of Arthritis and Musculoskeletal...Active, not recruiting
-
Massachusetts General HospitalWithdrawn
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Institute of Cancer Research, United KingdomRecruiting
-
Papworth Hospital NHS Foundation TrustCompletedMetastatic Cancer | Malignant MesotheliomaUnited Kingdom
-
Effector TherapeuticsTerminated
-
University of MichiganWithdrawnGastrointestinal MalignancyUnited States
-
John SarantopoulosNo longer availableAdvanced MalignancyUnited States
-
M.D. Anderson Cancer CenterICN PharmaceuticalsCompletedHematological MalignanciesUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Neoplasm | Immune System Disorder | Healthy Subject | Hematologic and Lymphocytic DisorderUnited States
-
HutchmedRecruitingIsocitrate Dehydrogenase Gene MutationSpain, United States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Novartis PharmaceuticalsCompleted
-
Royal Marsden NHS Foundation TrustUnknown
-
National Cancer Institute (NCI)CompletedCancer | Childhood MalignancyUnited States
-
American Society of HematologyActive, not recruitingBenign and Malignant Hematologic DiseasesUnited States
-
University of LeicesterEli Lilly and Company; GlaxoSmithKline; Merck Sharp & Dohme LLC; Roche Pharma AG; British Lung Foundation and other collaboratorsActive, not recruitingMesothelioma, MalignantUnited Kingdom
-
University of EdinburghNHS LothianCompleted
-
Patrick Wagner, MD, FACSList Biological Laboratories, IncRecruitingAbdominal Cancer | MalignancyUnited States
-
King's College LondonBayerUnknown
-
IncuronTerminatedHematological MalignanciesUnited States
-
Gemin XCompletedHematological MalignanciesUnited States, Canada
-
University of Alabama at BirminghamMerck Sharp & Dohme LLCCompleted
-
Cambridge University Hospitals NHS Foundation TrustRecruitingSpinal Cord Diseases | MyelopathyUnited Kingdom
-
Wales Cancer Trials UnitPierre Fabre LaboratoriesCompleted
-
King's College Hospital NHS TrustRecruiting
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLCRecruitingPneumonia | Hematologic Malignancy | Pseudomonas AeruginosaUnited States
-
Athanassios ArgirisUniversity of Pittsburgh; University of North Carolina, Chapel HillWithdrawnSalivary Gland MalignancyUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCancer and Aging Research GroupRecruitingLymphoma | Leukemia | MyelomaUnited States
-
Martin GutierrezHackensack Meridian Health; Karyopharm Therapeutics IncWithdrawn
-
Incyte CorporationWithdrawnSolid Tumors and Hematologic Malignancy | NSCLC (Non-small Cell Lung Carcinoma)United States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedMultiple Myeloma | Hodgkin's Lymphoma | AML | Hematologic Malignancy | NHL | CML | ALLUnited States
-
AUSL ROMAGNAInternational Society of Geriatric Oncology; European Society of Surgical Oncology and other collaboratorsUnknownElderly | Solid MalignancyUnited States, Poland, Italy, Greece, Israel, Netherlands, Norway, Portugal, Spain, United Kingdom
-
University of EdinburghNHS Lothian; Chief Scientist Office of the Scottish Government; Transfusion Medicine...CompletedAnemia | Blood Transfusion | Intensive CareUnited Kingdom
-
Barbara Ann Karmanos Cancer InstituteCompletedHematological MalignanciesUnited States
-
Antisoma ResearchCompletedMetastatic Renal Cell Carcinoma | Metastatic Malignant MelanomaUnited Kingdom, New Zealand
-
SCRI Development Innovations, LLCNovartisCompletedSolid Tumors | Refractory MalignancyUnited States
-
University of LeicesterGlaxoSmithKlineActive, not recruitingEosinophilia | COPDUnited Kingdom
-
BayerCompletedHematologic NeoplasmsSpain, United States, Germany, United Kingdom